Keywords: msf, calls, generic, 2nd-line, arv, combos, after
MSF calls for generic 2nd-line ARV combos
Article | 19 July 2004
After 24 months' antiretroviral treatment, 10%-30% of HIV/ AIDS patientsneed to switch from first- to second-line treatment, the aid agency Medecins ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
